01 /What it is
Tabimorelin is a synthetic peptidomimetic growth hormone secretagogue first described in the early 2000s. It is structurally related to the GHRP family and was investigated as an orally available extension of that research line.
02 /How it works
In research models, Tabimorelin is studied as an agonist at the ghrelin receptor with extended duration relative to short acting GHRPs. Its mechanism overlaps with the ghrelin receptor agonist pathway shared by Ipamorelin and Hexarelin.
03 /What researchers explore it for
Researchers have explored Tabimorelin in growth hormone secretagogue research, in oral bioavailability research, and in receptor duration research at the ghrelin receptor.
04 /Safety and interactions
Research interactions of note include co administration with other ghrelin receptor agonists and with GHRH analogs. Tabimorelin is for laboratory research use only and is not for human consumption. Not medical advice. Not intended to diagnose, treat, cure, or prevent any disease.
05 /Research notes
Compound family: peptidomimetic ghrelin receptor agonists. Frequently compared with MK-677 (Ibutamoren) and Hexarelin. The Apothify library lists Tabimorelin for encyclopedia coverage only.
Related peptides
MK-677 (Ibutamoren) · Hexarelin · Ipamorelin